Sage Capital Advisors,Llc Durect Corp Transaction History

Sage Capital Advisors,Llc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 11, 2019	SELL	$0.48 - $1.1 $1,440 - $3,300	-3,000 Reduced 42.86%	4,000 $2,000
Q3 2018 Nov 14, 2018	BUY	$1.06 - $1.69 $1,060 - $1,690	1,000 Added 16.67%	7,000 $8,000
Q2 2018 Aug 14, 2018	BUY	$1.56 - $2.51 $9,360 - $15,059	6,000 New	6,000 $9,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $173M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Sage Capital Advisors,Llc, based on Form 13F filings with the SEC.

Stay updated on Sage Capital Advisors,Llc with notifications on news.